News

In conjunction with the financing, Andrew Levin, M.D., Ph.D., managing director of RA Capital Management, will join Synthorx’s board of directors. Leveraging a synthetic biology breakthrough, Synthorx has

Under the terms of the agreement, Sapience will gain exclusive rights to the development and commercialization of intellectual property developed at Columbia University by Drs. Lloyd Greene and

West-Ward's Capecitabine Tablets are indicated for adjuvant treatment in patients with Dukes' C colon cancer, as monotherapy in metastatic colorectal cancer, and in combination with docetaxel or as

Under the terms of the agreement, PeptiDream will receive an undisclosed upfront payment, annual technology access payments, and is eligible to receive payments based on achievement of certain

CHI refers to several congenital disorders in which hypoglycemia is caused by excessive insulin secretion. Itis a rare genetic disorder in which the insulin cells of the pancreas

The equity stake is part of an agreement under which Shire granted three central nervous system (CNS) pre-clinical development programs to Chronos in return for milestones and an

Fast Track designation is granted by FDA to drugs that are under development for serious conditions and have the potential to fulfill an unmet medical need. It was

The 280,000ft² facility will serve as a major hub for the North American life science business of Merck. It will feature a customer collaboration laboratory and training center

With the new indication, patients with moderate to severe Alzheimer's disease, who are currently stabilized on Aricept, donepezil hydrochloride (10 mg), can now start combination therapy directly with